Name: | Description: | Size: | Format: | |
---|---|---|---|---|
329.27 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Objective: To identify the best available evidence on the efficacy of Reminiscence Therapy
in cognition, depressive symptoms and quality of life in elderly individuals with cognitive
impairment. Method: The methodology proposed by the Joanna Briggs Institute was
used. Studies focused on group Reminiscence Therapy aimed at institutionalized elderly
people with cognitive impairment aged 65 or over were considered. The critical analysis,
extraction and synthesis of results was performed by two independent researchers.
Results: Four randomized clinical trials and two quasi-experimental studies (n=296)
were included. Given the heterogeneous characteristics of studies found, it was impossible
to perform a meta-analysis. Of the six studies included, two presented statistically
significant results for efficacy in cognition, and three for efficacy in reducing depressive
symptoms. In none of the studies was evaluated the elderly’s quality of life. Conclusion:
Reminiscence Therapy has potential efficacy for maintaining cognition and decrease of
depressive symptomatology in the target population.
Description
Keywords
Aged Cognition Cognitive Dysfunction Depression Humans Institutionalization Psychotherapy Group Quality of Life Randomized Controlled Trials as Topic